Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...

This is a development tutorial for eBPF based on CO-RE (Compile Once, Run Everywhere). It provides practical eBPF development practices from beginner to advanced, including basic concepts, code ...

gollm is a Go package designed to help you build your own AI golems. Just as the mystical golem of legend was brought to life with sacred words, gollm empowers you to breathe life into your AI ...